SCA
CDLX icon

Stonebridge Capital Advisors’s Cardlytics CDLX Stock Holding History

Stonebridge Capital Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2
Closed -$1K – 1027
2021
Q4 		$1K Buy
+2
New +$1.53K ﹤0.01% 897

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

Stonebridge Capital Advisors's CDLX Position: Q1 2022 in Review

Stonebridge Capital Advisors sold out of Cardlytics (CDLX) in Q1 2022, closing a stake of 2 shares — an estimated $1K sold.

Stonebridge Capital Advisors first reported a position in CDLX in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 153 funds tracked by Wall St. Rank hold CDLX as of Q1 2022.

  • Stonebridge Capital Advisors reported no remaining Cardlytics position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 2 Cardlytics shares in Q1 2022, an estimated $1K.
  • Stonebridge Capital Advisors first reported a position in Cardlytics in Q4 2021 and held it in 1 quarter.
  • Stonebridge Capital Advisors's Cardlytics position peaked at $1K in Q4 2021.
  • 153 funds tracked by Wall St. Rank held Cardlytics as of Q1 2022.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.